Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1889019

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1889019

Benign Prostatic Hyperplasia Treatment Device Market Size, Share & Trends Analysis Report By Product (Resectoscopes, Urology Laser), By Treatment, By Procedure, By End-use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Benign Prostatic Hyperplasia Treatment Device Market Summary

The global benign prostatic hyperplasia treatment device market size was estimated at USD 1.67 billion in 2024 and is projected to reach USD 3.71 billion by 2033, growing at a CAGR of 9.40% from 2025 to 2033. The growing aging population is a key market driver for benign prostatic hyperplasia (BPH) treatment devices, as BPH incidence increases with age.

Rising cases of lower urinary tract symptoms (LUTS) and other urological conditions are also fueling demand for effective treatments. There is a strong shift toward minimally invasive procedures, which offer shorter recovery times, fewer postoperative complications, and improved patient outcomes compared to traditional surgery. Advances in BPH treatment technology are expanding options for both patients and physicians. In addition, increased awareness and earlier diagnosis of BPH are contributing to the global adoption of advanced treatment devices.

The prostate grows larger because of benign prostatic hyperplasia (BPH). Due to aging, the majority of the male population experiences prostate-related issues such as BPH. A sudden urge to urinate and difficulties urinating are symptoms associated with benign prostatic hyperplasia. The treatment options include medication, surgery, and minimally invasive procedures. The market for devices used to treat benign prostatic hyperplasia is expanding at an accelerated rate, driven by the increasing elderly population.

The increasing elderly male population is contributing to greater demand for benign prostatic hyperplasia (BPH) treatment devices. With advancing age, the prevalence of prostate enlargement and lower urinary tract symptoms rises, leading to a preference for advanced and minimally invasive therapies. Innovations, including laser systems, prostatic urethral lifts, and water vapor ablation technology, are gaining popularity. Enhanced awareness, improved diagnostic rates, and expanded access to healthcare services further accelerate market growth. UnitedHealthcare projects that the number of Americans aged 65 and older will increase from 58 million in 2022 to 82 million by 2050.

The market is expected to grow due to increasing demand for minimally invasive procedures and ongoing innovations in novel BPH treatment devices. Minimally invasive surgeries are primarily performed as outpatient procedures under minimal anesthesia, resulting in a faster recovery compared to traditional open surgeries. Furthermore, the widespread adoption of robot-assisted surgical methods, combined with favorable reimbursement options, is actively accelerating market growth.

For instance, in May 2023, Teleflex Incorporated announced new research findings that conclusively demonstrate the long-term efficacy of the prostatic urethral lift procedure with the UroLift System. Data indicate that this system has fewer complications compared to other established minimally invasive procedures for BPH. The UroLift System has become the leading minimally invasive treatment for benign prostatic hyperplasia, adopted by doctors in the U.S. Collectively, these compelling factors are expected to increase market demand in the coming years.

Global Benign Prostatic Hyperplasia Treatment Device Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global benign prostatic hyperplasia (BPH) treatment device market report based on treatment, procedure, product, end-use, and region:

  • Treatment Outlook (Revenue, USD Million, 2021 - 2033)
  • Minimal Invasive Surgery
  • Invasive Surgery
  • Procedure Outlook (Revenue, USD Million, 2021 - 2033)
  • Transurethral Resection of the Prostate
  • Prostate Laser Surgery
  • Transurethral Microwave Thermotherapy
  • Transurethral Needle Ablation of the Prostate
  • Prostatic Urethral Lift
  • Water Vapor Therapy
  • Robot-Assisted Laparoscopic Prostatectomy
  • Aquablation Therapy
  • Prostatic Artery Embolization
  • Open Prostatectomy
  • Bipolar Enucleation of Prostate
  • Transurethral Incision of the Prostate
  • High-Intensity Focused Ultrasound
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Resectoscopes
  • Urology Laser
  • Radiofrequency Ablation
  • Electrodes
  • Catheters
  • Prostatic Stents
  • Implants
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Facilities
  • Research and Manufacturing
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-119-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Treatment
    • 1.1.2. Procedure
    • 1.1.3. Product
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. Product outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Benign Prostatic Hyperplasia (BPH) Treatment Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Increasing prevalence of urinary disorders
      • 3.2.1.3. Shift towards minimally invasive prostatic procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of the treatment
      • 3.2.2.2. Strict government regulations
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing awareness & early diagnosis
      • 3.2.3.2. Medical tourism growth
      • 3.2.3.3. Technological advancements
    • 3.2.4. Market challenges analysis
      • 3.2.4.1. Limited awareness in emerging regions
      • 3.2.4.2. Competition from pharmacotherapy
  • 3.3. Benign Prostatic Hyperplasia (BPH) Treatment Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Treatment Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Minimal Invasive Surgery
    • 4.1.2. Invasive Surgery
  • 4.2. Treatment Market Share, 2021 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Market by Treatment Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033, for the following
    • 4.5.1. Minimal Invasive Surgery
      • 4.5.1.1. Minimal invasive surgery market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.5.2. Invasive Surgery
      • 4.5.2.1. Invasive surgery market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Procedure Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Procedure Market Share, 2021 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device Market by Procedure Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033, for the following
    • 5.5.1. Transurethral Microwave Thermotherapy
      • 5.5.1.1. Transurethral microwave thermotherapy market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.2. Transurethral Needle Ablation of the Prostate
      • 5.5.2.1. Transurethral needle ablation of the prostate market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.3. Prostatic Urethral Lift
      • 5.5.3.1. Prostatic urethral lift market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.4. Water Vapour Therapy
      • 5.5.4.1. Water vapour therapy market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.5. Robot-Assisted Laparoscopic Prostatectomy
      • 5.5.5.1. Robot-assisted laparoscopic prostatectomy market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.6. Prostate Laser Surgery
      • 5.5.6.1. Prostate laser surgery market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.7. Aquablation Therapy
      • 5.5.7.1. Aquablation therapy market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.8. Prostatic Artery Embolization
      • 5.5.8.1. Prostatic artery embolization market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.9. Open Prostatectomy
      • 5.5.9.1. Open prostatectomy market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.10. Transurethral Resection of the Prostate
      • 5.5.10.1. Transurethral resection of the prostate market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.11. Bipolar Enucleation of Prostate
      • 5.5.11.1. Bipolar enucleation of prostate market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.12. Transurethral Incision of the Prostate
      • 5.5.12.1. Transurethral incision of the prostate market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.13. High-Intensity Focused Ultrasound
      • 5.5.13.1. High-intensity focused ultrasound market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Product Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Product Market Share, 2021 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device Market by Product Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 6.5.1. Resectoscopes
      • 6.5.1.1. Resectoscopes market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.5.2. Urology Laser
      • 6.5.2.1. Urology laser market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.5.3. Radiofrequency Ablation
      • 6.5.3.1. Radiofrequency ablation market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.5.4. Electrodes
      • 6.5.4.1. Electrodes market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.5.5. Catheter
      • 6.5.5.1. Catheter market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.5.6. Prostatic Stents
      • 6.5.6.1. Prostatic stents market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.5.7. Implants
      • 6.5.7.1. Implants market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.5.8. Others
      • 6.5.8.1. Others market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: End Use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. End Use Market Share, 2021 & 2033
  • 7.3. Segment Dashboard
  • 7.4. Global Benign Prostatic Hyperplasia (BPH) Treatment Device by End Use Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
    • 7.5.1. Hospitals
      • 7.5.1.1. Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.2. Specialty facilities
      • 7.5.2.1. Specialty facilities market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.3. Research and Manufacturing
      • 7.5.3.1. Research and manufacturing market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Benign Prostatic Hyperplasia (BPH) Treatment Device Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2021 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2025 to 2033:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Canada market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. UK market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Germany market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. France market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Italy market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Spain market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Norway market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Japan market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. China market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. India market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Australia market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. UAE market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Karl Storz
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Boston Scientific Corporation
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Olympus America
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Dornier MedTech.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. biolitec Holding GmbH & Co KG
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. CooK
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Teleflex Incorporated
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Urotronic
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Coloplast Group
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. PROCEPT BioRobotics Corporation
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-119-1

List of Tables

  • Table 1 List of regulatory bodies for different countries
  • Table 2 Key companies' product launches
  • Table 3 Key companies' mergers and acquisitions
  • Table 4 Key companies' collaboration
  • Table 5 Other strategic initiatives of companies
  • Table 6 North America benign prostatic hyperplasia (BPH) treatment device market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 8 North America benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 9 North America benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 10 North America benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 12 U.S. benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 13 U.S. benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 14 U.S. benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Canada benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 16 Canada benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 17 Canada benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 18 Canada benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Mexico benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 20 Mexico benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 21 Mexico benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 22 Mexico benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Europe benign prostatic hyperplasia (BPH) treatment device market, by country, 2021 - 2033 (USD Million)
  • Table 24 Europe benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 25 Europe benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 26 Europe benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 27 Europe benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 28 UK benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 29 UK benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 30 UK benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 31 UK benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Germany benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 33 Germany benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 34 Germany benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 35 Germany benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 36 France benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 37 France benign prostatic hyperplasia (BPH) treatment device market, by Procedure, 2021 - 2033 (USD Million)
  • Table 38 France benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 39 France benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Italy benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 41 Italy benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 42 Italy benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 43 Italy benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Spain benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 45 Spain benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 46 Spain benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 47 Spain benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Norway benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 49 Norway benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 50 Norway benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 51 Norway benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Sweden benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 53 Sweden benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 54 Sweden benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 55 Sweden benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 56 Denmark benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 57 Denmark benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 58 Denmark benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 59 Denmark benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by country, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Japan benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 66 Japan benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 67 Japan benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 68 Japan benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 69 China benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 70 China benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 71 China benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 72 China benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 73 India benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 74 India benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 75 India benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 76 India benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Australia benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 78 Australia benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 79 Australia benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 80 Australia benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 81 South Korea benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 82 South Korea benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 83 South Korea benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Korea benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 85 Thailand benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 86 Thailand benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 87 Thailand benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 88 Thailand benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Latin America benign prostatic hyperplasia (BPH) treatment device market, by country, 2021 - 2033 (USD Million)
  • Table 90 Latin America benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 91 Latin America benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 92 Latin America benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 93 Latin America benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 94 Brazil benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 95 Brazil benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 96 Brazil benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 97 Brazil benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 98 Argentina benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 99 Argentina benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 100 Argentina benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 101 Argentina benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 102 Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by country, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 107 South Africa benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 108 South Africa benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 109 South Africa benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 110 South Africa benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 111 Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 115 UAE benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 116 UAE benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 117 UAE benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 118 UAE benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)
  • Table 119 Kuwait benign prostatic hyperplasia (BPH) treatment device market, by treatment, 2021 - 2033 (USD Million)
  • Table 120 Kuwait benign prostatic hyperplasia (BPH) treatment device market, by procedure, 2021 - 2033 (USD Million)
  • Table 121 Kuwait benign prostatic hyperplasia (BPH) treatment device market, by product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait benign prostatic hyperplasia (BPH) treatment device market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Benign prostatic hyperplasia (BPH) treatment device market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement process
  • Fig. 4 Primary research pattern
  • Fig. 5 Benign prostatic hyperplasia (BPH) treatment device market snapshot, 2024 (USD Million)
  • Fig. 6 Segment snapshot, USD Million
  • Fig. 7 Competitive landscape snapshot
  • Fig. 8 Penetration & growth prospect mapping, by product
  • Fig. 9 Market driver analysis (Current & future impact)
  • Fig. 10 Market restraint analysis (Current & future impact)
  • Fig. 11 Benign prostatic hyperplasia treatment device market, Treatment outlook key takeaways (USD Million)
  • Fig. 12 Benign prostatic hyperplasia treatment device market: Treatment movement analysis (USD Million), 2025 & 2033
  • Fig. 13 Minimal invasive surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Invasive surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Benign prostatic hyperplasia treatment device market, Procedure outlook key takeaways (USD Million)
  • Fig. 16 Benign prostatic hyperplasia treatment device market: Procedure movement analysis (USD Million), 2025 & 2033
  • Fig. 17 Transurethral microwave thermotherapy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Transurethral needle ablation of the prostate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Prostatic urethral lift market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Water vapour therapy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Robot-assisted laparoscopic prostatectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Prostate laser surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Aquablation therapy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Prostatic artery embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Open prostatectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Transurethral resection of the prostate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Bipolar enucleation of prostate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Transurethral incision of the prostate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 High-intensity focused ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Benign prostatic hyperplasia treatment device market, Product outlook key takeaways (USD Million)
  • Fig. 31 Benign prostatic hyperplasia treatment device market: Product movement analysis (USD Million), 2025 & 2033
  • Fig. 32 Resectoscopes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Urology laser market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Radiofrequency ablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Electrodes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Prostatic stents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Benign prostatic hyperplasia treatment device market, End Use outlook key takeaways (USD Million)
  • Fig. 41 Benign prostatic hyperplasia treatment device market: End Use movement analysis (USD Million), 2025 & 2033
  • Fig. 42 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Specialty facilities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Research and manufacturing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Benign prostatic hyperplasia treatment device market: Regional key takeaways (USD Million)
  • Fig. 46 Benign prostatic hyperplasia treatment device market: Regional outlook, 2025 & 2033, USD Million
  • Fig. 47 North America benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 US benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Canada benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Europe benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 UK benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Germany benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 France benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Spain benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Italy benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Norway benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 China benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Japan benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 India benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Australia benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Thailand benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Middle East and Africa benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 South Africa benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 UAE benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Kuwait benign prostatic hyperplasia treatment device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 List of key emerging companies/procedure disruptors/innovators
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!